26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

BackgroundThe antifibrinolytic tranexamic acid reduces surgical blood loss, but studies have not identified an ideal route of administration.We tried to identify whether intra-articular route of administration of tranexamic acid is superior to its intravenous route of administration in reducing blood loss in post-operative period, number of transfusion units and complications e.g. thromboembolic phenomenon and DVT.We prospectively compared the two routes of administration (I/A and I/V) in a study population of 28 patients. In all the patients staged bilateral TKA was performed, one side receiving tranexamic acid I/A and the other I/V.…mehr

Produktbeschreibung
BackgroundThe antifibrinolytic tranexamic acid reduces surgical blood loss, but studies have not identified an ideal route of administration.We tried to identify whether intra-articular route of administration of tranexamic acid is superior to its intravenous route of administration in reducing blood loss in post-operative period, number of transfusion units and complications e.g. thromboembolic phenomenon and DVT.We prospectively compared the two routes of administration (I/A and I/V) in a study population of 28 patients. In all the patients staged bilateral TKA was performed, one side receiving tranexamic acid I/A and the other I/V.
Autorenporträt
El Dr. Rohan Krishnan es un joven estudiante brillante, ha persuadido a su MS Ortopedia de ESI-PGIMSR, Nueva Delhi. él fue todo India Rango 1645 en NEET PG examen de ingreso de 2017 y superó su examen de la universidad MS en 2020. Aparte de los académicos, es una figura muy conocida en el círculo de médicos y es secretario de la Asociación Médica de la India y ex presidente de la R.D.A.